Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.
RVDuchenne
1 other identifier
interventional
12
1 country
1
Brief Summary
Duchenne's Muscular Dystrophy and Becker Dystrophy, hereafter DMD and BMD, is a serious and progressive disease that affects 1 in 3,500-6,000 males born alive. Scale 6-minute walking test, is used for determine the inclusion of children with DMD in pharmacological studies. Furthemore, is used to verify a training effectiveness assessing muscular endurance and cardio-respiratory functions. This Research evaluates the feasibility and effectiveness of a multimodal physiotherapist program with virtual reality glasses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2019
CompletedFirst Posted
Study publicly available on registry
March 18, 2019
CompletedStudy Start
First participant enrolled
March 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2023
CompletedMay 13, 2024
May 1, 2024
1.6 years
March 9, 2019
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in six meter walking test (6-MWT) score
Six-meter walking test is a a well-established outcome measure in a variety of diseases. It is accurate, reproducible, simple to administer, and well tolerated. The 6MWT is a robust assessment tool for use in clinical trials given its ability to quantitatively evaluate ambulation in a controlled environment.
Baseline, up to six weeks
Secondary Outcomes (4)
EPInfant
through study completion, average 6 weeks
NSAA o North Star Ambulatory Assessment
Baseline, up to 6 weeks
MFM o Motor Function Measure
Baseline, up to 6 weeks
Kids Screen-52
Baseline.
Study Arms (2)
Multimodal physiotherapy program with RV
EXPERIMENTALThe RV intervention group receives a tele multimodal physiotherapy program with tradicional exercises of physiotherapy like stretching, aerobic, training through videos and gamification with VR glasses.
Traditional physiotherapy program
ACTIVE COMPARATORTraditional intervention group receives assistance of a program of physiotherapy traditional without virtual reality glasses.
Interventions
Physiotherapy Programm includes: respiratory physiotherapy, stretching, resistance training, aerobic training and adaptation and training with virtual reality glasses and relaxation.
Multimodal physiotherapy Programm includes: traditional physiotherapy, stretching, massage.
Eligibility Criteria
You may qualify if:
- Children between 4 and 15 years
- Duchenne and Becker Diagnosis ICD-10 issued by specialist in neurology.
- Children who can walk 10 m at last 120 seconds.
- First punctuation of North Start Ambulatory assessment bigger than 20 points.
You may not qualify if:
- An other Dystrophies.
- Older than 10 years.
- Not Physiotherapy. Not walk.
- Asociated heart disease Sprains, fractures. FC \>120, Sat O2 \<89%.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Málaga
Málaga, 29071, Spain
Related Publications (2)
Baeza-Barragan MR, Labajos Manzanares MT, Ruiz Vergara C, Casuso-Holgado MJ, Martin-Valero R. The Use of Virtual Reality Technologies in the Treatment of Duchenne Muscular Dystrophy: Systematic Review. JMIR Mhealth Uhealth. 2020 Dec 8;8(12):e21576. doi: 10.2196/21576.
PMID: 33289679BACKGROUNDBaeza-Barragan MR, Labajos Manzanares MT, Amaya-Alvarez MC, Morales Vega F, Rodriguez Ruiz J, Martin-Valero R. Effectiveness of a 5-Week Virtual Reality Telerehabilitation Program for Children With Duchenne and Becker Muscular Dystrophy: Prospective Quasi-Experimental Study. JMIR Serious Games. 2023 Nov 15;11:e48022. doi: 10.2196/48022.
PMID: 37990809RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rocío Martín Valero, PhD
Universidad de Málaga
- STUDY DIRECTOR
Maria Teresa Labajos Manzanares, PhD
Universidad de Málaga
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 9, 2019
First Posted
March 18, 2019
Study Start
March 15, 2021
Primary Completion
October 30, 2022
Study Completion
March 11, 2023
Last Updated
May 13, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
an average of 2 years